PHAXIAM Therapeutics S.A. Current Deferred Income Including Current Contract Liabilities
PHAXIAM Therapeutics S.A. had Current Deferred Income Including Current Contract Liabilities of EUR 420.00 thousand as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes
ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities · last filed 2023-09-26
- 2023-06-30: Current Deferred Income Including Current Contract Liabilities 420.00K EUR.
- 2022-12-31: Current Deferred Income Including Current Contract Liabilities 51.00K EUR.
- 2022-06-30: Current Deferred Income Including Current Contract Liabilities 61.00K EUR.
- 2021-12-31: Current Deferred Income Including Current Contract Liabilities 93.00K EUR.
| Period end | Current Deferred Income Including Current Contract Liabilities |
|---|---|
| 2023-06-30 | 420.00K EUR 6-K · filed 2023-09-26 |
| 2022-12-31 | 51.00K EUR 6-K · filed 2023-09-26 |
| 2022-06-30 | 61.00K EUR 6-K · filed 2022-09-12 |
| 2021-12-31 | 93.00K EUR 20-F · filed 2023-03-28 |
| 2020-12-31 | 148.00K EUR 20-F · filed 2023-03-28 |
| 2019-12-31 | 61.00K EUR 20-F · filed 2022-04-27 |